This website is intended for US Healthcare Professionals.
This website is intended for US Healthcare Professionals.
REBLOZYL® (luspatercept-aamt) is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions.
REBLOZYL® (luspatercept-aamt) is indicated for the treatment of anemia without previous erythropoiesis stimulating agent use (ESA-naïve) in adult patients with very low- to intermediate-risk myelodysplastic syndromes (MDS) who may require regular red blood cell (RBC) transfusions.
REBLOZYL® (luspatercept-aamt) is indicated for the treatment of anemia failing an erythropoiesis stimulating agent and requiring 2 or more red blood cell (RBC) units over 8 weeks in adult patients with very low- to intermediate-risk myelodysplastic syndromes with ring sideroblasts (MDS-RS) or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
REBLOZYL is not indicated for use as a substitute for RBC transfusions in patients who require immediate correction of anemia.
This dosing calculator is being provided “AS IS” and is intended for use only by qualified healthcare providers. All calculations should be confirmed before use. Bristol Myers Squibb makes no claims as to the accuracy of the information contained herein. The information being provided is not a substitute for clinical judgment. Neither Bristol Myers Squibb, nor any other party involved in the preparation or publication of this site, shall be liable to you or others for any decisions made or actions taken by you or others in reliance on this information.
Click “I UNDERSTAND” to proceed or “CANCEL” to return.
Request a Rep
SUPPORT AND RESOURCES: ACCESS AND FINANCIAL RESOURCES
REBLOZYL can only be purchased through authorized distributors for administration in physician offices, hospital outpatient facilities, institutions, Veterans Affairs, and the Department of Defense. The following distributors are authorized to sell REBLOZYL and are able to service qualified accounts.
Authorized distributor network
PHYSICIAN OFFICES | ||
---|---|---|
Authorized Distributor | Phone/Fax | Website |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-877-453-3972 | specialtyonline.cardinalhealth.com |
CuraScript Specialty Distribution Mon-Fri, 8:00 AM-7:00 PM ET |
1-877-599-7748 | www.curascriptsd.com |
McKesson Specialty Health Mon-Fri, 7:00 AM-7:00 PM CT |
1-800-482-6700 | mscs.mckesson.com |
Morris & Dickson Specialty Mon-Fri, 8:00 AM-6:00 PM CT |
1-800-710-6100 1-318-524-3096 (Fax) |
www.mdspecialtydist.com |
Oncology Supply Mon-Fri, 8:00 AM-7:00 PM CT |
1-800-633-7555 | www.oncologysupply.com |
HOSPITALS AND INFUSION CENTERS | ||
Authorized Distributor | Phone/Fax | Website |
ASD Healthcare Mon-Thurs, 7:00 AM-6:30 PM CT; Friday, 7:00 AM-6 PM CT |
1-800-746-6273 1-800-547-9413 (Fax) |
www.asdhealthcare.com |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-866-677-4844 1-614-553-6301 (Fax) |
orderexpress.cardinalhealth.com |
DMS Pharmaceutical Group, Inc. Mon-Fri, 8:30 AM-5:00 PM CT |
1-877-788-1100 1-847-518-1105 (Fax) |
www.dmspharma.com |
McKesson Plasma and Biologics Mon-Fri, 8:00 AM-6:30 PM CT |
1-877-625-2566 1-888-752-7626 (Fax) |
connect.mckesson.com |
PUERTO RICO HOSPITALS AND CLINICS | ||
Authorized Distributor | Phone/Fax | Website |
Cardinal Puerto Rico (Borschow) | 1-787-625-4200 | orderexpress.cardinalhealth.com |
Cesar Castillo, Inc. | 1-787-641-5242 (Hospitals) 1-787-641-5082 (Specialty Pharmacies) 1-787-999-1614 (Fax) |
www.facilfarmaciacci.com |
PHYSICIAN OFFICES | |
---|---|
Authorized Distributor | Phone/Fax/Website |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-877-453-3972 specialtyonline. cardinalhealth.com |
CuraScript Specialty Distribution Mon-Fri, 8:00 AM-7:00 PM ET |
1-877-599-7748 www.curascriptsd.com |
McKesson Specialty Health Mon-Fri, 7:00 AM-7:00 PM CT |
1-800-482-6700 mscs.mckesson.com |
Morris & Dickson Specialty Mon-Fri, 8:00 AM-6:00 PM CT |
1-800-710-6100 1-318-524-3096 (Fax) www.mdspecialtydist.com |
Oncology Supply Mon-Fri, 8:00 AM-7:00 PM CT |
1-800-633-7555 www.oncologysupply.com |
HOSPITALS AND INFUSION CENTERS | |
Authorized Distributor | Phone/Fax/Website |
ASD Healthcare Mon-Thurs, 7:00 AM-6:30 PM CT; Friday, 7:00 AM-6 PM CT |
1-800-746-6273 1-800-547-9413 (Fax) www.asdhealthcare.com |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-866-677-4844 1-614-553-6301 (Fax) cardinalhealth.com |
DMS Pharmaceutical Group, Inc. Mon-Fri, 8:30 AM-5:00 PM CT |
1-877-788-1100 1-847-518-1105 (Fax) www.dmspharma.com |
McKesson Plasma and Biologics Mon-Fri, 8:00 AM-6:30 PM CT |
1-877-625-2566 1-888-752-7626 (Fax) connect.mckesson.com |
PUERTO RICO HOSPITALS AND CLINICS | |
Authorized Distributor | Phone/Fax/Website |
Cardinal Puerto Rico (Borschow) | 1-787-625-4200 orderexpress. cardinalhealth.com |
Cesar Castillo, Inc. | 1-787-641-5242 (Hospitals) 1-787-641-5082 (Specialty Pharmacies) 1-787-999-1614 (Fax) www.facilfarmaciacci.com |
Above information is accurate as of 04/22. The most updated distributors can be found on
https://www.bmsaccesssupport.bmscustomerconnect.com/reblozyl/billing-diagnosis-codes.
The REBLOZYL distribution program includes extended payment terms to Bristol Myers Squibb authorized REBLOZYL distributors. Healthcare providers and institutions should contact their REBLOZYL distributor to understand specific payment terms that may be available to them from their distributor.
NDC and packaging information
Product/ Strength |
Package/ Description |
11-Digit NDC |
---|---|---|
REBLOZYL injection 25 mg/vial | 25-mg lyophilized powder for solution for injection in a single-dose vial for reconstitution | 59572-0711-01 |
REBLOZYL injection 75 mg/vial | 75-mg lyophilized powder for solution for injection in a single-dose vial for reconstitution | 59572-0775-01 |
The red zero converts the 10-digit NDC to the 11-digit NDC. Payer requirements regarding the use of NDCs may vary. Electronic data exchange generally requires use of the 11-digit NDC.
HCPCS codes | ||
---|---|---|
J0896 | Injection, luspatercept-aamt, 0.25 mg | |
CPT® codes | ||
96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | |
96401 (for potential use only in MDS) |
Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | |
Billing units | ||
1 unit = 0.25 mg | 25-mg vial | 100 units |
75-mg vial | 300 units | |
ICD-10-CM diagnosis codes for MDS | ||
D46.1 | Refractory anemia with ring sideroblasts | |
D46.A | Refractory cytopenia with multilineage dysplasia | |
D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts | |
D46.4 | Refractory anemia, unspecified | |
D46.Z | Other myelodysplastic syndromes | |
D46.9 | Myelodysplastic syndrome, unspecified | |
ICD-10-CM diagnosis codes for beta-thalassemia | ||
D56.1 | Beta-thalassemia
|
|
D56.5 | Hemoglobin E beta-thalassemia |
CPT=Current Procedural Terminology; HCPCS=Healthcare Common Procedure Coding System; ICD-10-CM=International Classification of Diseases, Tenth Revision, Clinical Modification.
CPT® codes and descriptions are copyright 2020 American Medical Association (AMA). All rights reserved. CPT® is a registered trademark of the AMA.
The 2020 version of ICD-10-CM took effect on October 1, 2019.
The information contained herein is not intended to provide specific coding and reimbursement advice for any specific patient or situation. You should check with your coding specialist to ensure appropriate submissions.
Consult a reference guide for reimbursement and coding for REBLOZYL
The Reimbursement and Coding Guide provides coding, billing, and reimbursement information to support practice administrators.
Download the GuideAvailable Through
Bristol Myers Squibb is committed to helping appropriate patients initiate and maintain access to our medications during the treatment journey. That’s why we created BMS Access Support®, which offers benefits reviews, prior authorization assistance, and appeal process support, as well as an easy-to-initiate co-pay assistance process and information on financial support. The BMS Access Support Co-pay Assistance Program assists with out-of-pocket co-payment or co-insurance requirements for eligible, commercially insured patients who have been prescribed certain Bristol Myers Squibb products, including REBLOZYL. For more information, visit BMS Access Support, or call BMS Access Support at
Available Through
At BMS, we provide support with purpose.
The BMS Access Support program is dedicated to helping patients access their prescribed BMS medications. We may offer benefit investigations, prior authorizations assistance, appeals process support, and information on financial support options. The BMS Access Support Co-Pay Assistance Program assists with out-of-pocket co-payment or
For more information, visit BMS Access Support or call BMS Access Support at
SUPPORT AND RESOURCES: ACCESS AND FINANCIAL RESOURCES
REBLOZYL can only be purchased through authorized distributors for administration in physician offices, hospital outpatient facilities, institutions, Veterans Affairs, and the Department of Defense. The following distributors are authorized to sell REBLOZYL and are able to service qualified accounts.
Authorized distributor network
PHYSICIAN OFFICES | ||
---|---|---|
Authorized Distributor | Phone/Fax | Website |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-877-453-3972 | specialtyonline.cardinalhealth.com |
CuraScript Specialty Distribution Mon-Fri, 8:00 AM-7:00 PM ET |
1-877-599-7748 | www.curascriptsd.com |
McKesson Specialty Health Mon-Fri, 7:00 AM-7:00 PM CT |
1-800-482-6700 | mscs.mckesson.com |
Morris & Dickson Specialty Mon-Fri, 8:00 AM-6:00 PM CT |
1-800-710-6100 1-318-524-3096 (Fax) |
www.mdspecialtydist.com |
Oncology Supply Mon-Fri, 8:00 AM-7:00 PM CT |
1-800-633-7555 | www.oncologysupply.com |
HOSPITALS AND INFUSION CENTERS | ||
Authorized Distributor | Phone/Fax | Website |
ASD Healthcare Mon-Thurs, 7:00 AM-6:30 PM CT; Friday, 7:00 AM-6 PM CT |
1-800-746-6273 1-800-547-9413 (Fax) |
www.asdhealthcare.com |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-866-677-4844 1-614-553-6301 (Fax) |
orderexpress.cardinalhealth.com |
DMS Pharmaceutical Group, Inc. Mon-Fri, 8:30 AM-5:00 PM CT |
1-877-788-1100 1-847-518-1105 (Fax) |
www.dmspharma.com |
McKesson Plasma and Biologics Mon-Fri, 8:00 AM-6:30 PM CT |
1-877-625-2566 1-888-752-7626 (Fax) |
connect.mckesson.com |
PUERTO RICO HOSPITALS AND CLINICS | ||
Authorized Distributor | Phone/Fax | Website |
Cardinal Puerto Rico (Borschow) | 1-787-625-4200 | orderexpress.cardinalhealth.com |
Cesar Castillo, Inc. | 1-787-641-5242 (Hospitals) 1-787-641-5082 (Specialty Pharmacies) 1-787-999-1614 (Fax) |
www.facilfarmaciacci.com |
PHYSICIAN OFFICES | |
---|---|
Authorized Distributor | Phone/Fax/Website |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-877-453-3972 specialtyonline. cardinalhealth.com |
CuraScript Specialty Distribution Mon-Fri, 8:00 AM-7:00 PM ET |
1-877-599-7748 www.curascriptsd.com |
McKesson Specialty Health Mon-Fri, 7:00 AM-7:00 PM CT |
1-800-482-6700 mscs.mckesson.com |
Morris & Dickson Specialty Mon-Fri, 8:00 AM-6:00 PM CT |
1-800-710-6100 1-318-524-3096 (Fax) www.mdspecialtydist.com |
Oncology Supply Mon-Fri, 8:00 AM-7:00 PM CT |
1-800-633-7555 www.oncologysupply.com |
HOSPITALS AND INFUSION CENTERS | |
Authorized Distributor | Phone/Fax/Website |
ASD Healthcare Mon-Thurs, 7:00 AM-6:30 PM CT; Friday, 7:00 AM-6 PM CT |
1-800-746-6273 1-800-547-9413 (Fax) www.asdhealthcare.com |
Cardinal Health Specialty Pharmaceutical Distribution Mon-Fri, 7:00 AM-6:00 PM CT |
1-866-677-4844 1-614-553-6301 (Fax) cardinalhealth.com |
DMS Pharmaceutical Group, Inc. Mon-Fri, 8:30 AM-5:00 PM CT |
1-877-788-1100 1-847-518-1105 (Fax) www.dmspharma.com |
McKesson Plasma and Biologics Mon-Fri, 8:00 AM-6:30 PM CT |
1-877-625-2566 1-888-752-7626 (Fax) connect.mckesson.com |
PUERTO RICO HOSPITALS AND CLINICS | |
Authorized Distributor | Phone/Fax/Website |
Cardinal Puerto Rico (Borschow) | 1-787-625-4200 orderexpress. cardinalhealth.com |
Cesar Castillo, Inc. | 1-787-641-5242 (Hospitals) 1-787-641-5082 (Specialty Pharmacies) 1-787-999-1614 (Fax) www.facilfarmaciacci.com |
Above information is accurate as of 04/22. The most updated distributors can be found on
https://www.bmsaccesssupport.bmscustomerconnect.com/reblozyl/billing-diagnosis-codes.
The REBLOZYL distribution program includes extended payment terms to Bristol Myers Squibb authorized REBLOZYL distributors. Healthcare providers and institutions should contact their REBLOZYL distributor to understand specific payment terms that may be available to them from their distributor.
NDC and packaging information
Product/ Strength |
Package/ Description |
11-Digit NDC |
---|---|---|
REBLOZYL injection 25 mg/vial | 25-mg lyophilized powder for solution for injection in a single-dose vial for reconstitution | 59572-0711-01 |
REBLOZYL injection 75 mg/vial | 75-mg lyophilized powder for solution for injection in a single-dose vial for reconstitution | 59572-0775-01 |
The red zero converts the 10-digit NDC to the 11-digit NDC. Payer requirements regarding the use of NDCs may vary. Electronic data exchange generally requires use of the 11-digit NDC.
HCPCS codes | ||
---|---|---|
J0896 | Injection, luspatercept-aamt, 0.25 mg | |
CPT® codes | ||
96372 | Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular | |
96401 (for potential use only in MDS) |
Chemotherapy administration, subcutaneous or intramuscular; non-hormonal anti-neoplastic | |
Billing units | ||
1 unit = 0.25 mg | 25-mg vial | 100 units |
75-mg vial | 300 units | |
ICD-10-CM diagnosis codes for MDS | ||
D46.1 | Refractory anemia with ring sideroblasts | |
D46.A | Refractory cytopenia with multilineage dysplasia | |
D46.B | Refractory cytopenia with multilineage dysplasia and ring sideroblasts | |
D46.4 | Refractory anemia, unspecified | |
D46.Z | Other myelodysplastic syndromes | |
D46.9 | Myelodysplastic syndrome, unspecified | |
ICD-10-CM diagnosis codes for beta-thalassemia | ||
D56.1 | Beta-thalassemia
|
|
D56.5 | Hemoglobin E beta-thalassemia |
CPT=Current Procedural Terminology; HCPCS=Healthcare Common Procedure Coding System; ICD-10-CM=International Classification of Diseases, Tenth Revision, Clinical Modification.
CPT® codes and descriptions are copyright 2020 American Medical Association (AMA). All rights reserved. CPT® is a registered trademark of the AMA.
The 2020 version of ICD-10-CM took effect on October 1, 2019.
The information contained herein is not intended to provide specific coding and reimbursement advice for any specific patient or situation. You should check with your coding specialist to ensure appropriate submissions.
Consult a reference guide for reimbursement and coding for REBLOZYL
The Reimbursement and Coding Guide provides coding, billing, and reimbursement information to support practice administrators.
Download the GuideAvailable Through
Bristol Myers Squibb is committed to helping appropriate patients initiate and maintain access to our medications during the treatment journey. That’s why we created BMS Access Support®, which offers benefits reviews, prior authorization assistance, and appeal process support, as well as an easy-to-initiate co-pay assistance process and information on financial support. The BMS Access Support Co-pay Assistance Program assists with out-of-pocket co-payment or co-insurance requirements for eligible, commercially insured patients who have been prescribed certain Bristol Myers Squibb products, including REBLOZYL. For more information, visit BMS Access Support, or call BMS Access Support at
Available Through
At BMS, we provide support with purpose.
The BMS Access Support program is dedicated to helping patients access their prescribed BMS medications. We may offer benefit investigations, prior authorizations assistance, appeals process support, and information on financial support options. The BMS Access Support Co-Pay Assistance Program assists with out-of-pocket co-payment or
For more information, visit BMS Access Support or call BMS Access Support at
References: 1. REBLOZYL [US Prescribing Information]. Summit, NJ: Celgene Corporation; 2023. 2. Data on file package: BMS-REF-ACE-536-0009. Princeton, NJ: Bristol-Myers Squibb Company; 2023.